HEXO DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages HEXO Corp. (HEXO) Investors With Significant Losses to Contact Firm; Application Deadline Looming

1/19, 12:33 AM (Source: GlobeNewswire)

SAN FRANCISCO, Jan. 18, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in HEXO Corp. (NYSE: HEXO) who have suffered significant losses to submit their losses now to learn if they qualify to recover their investment losses.  Hagens Berman has filed a class action complaint against HEXO and its senior executives and the Jan. 27, 2020 application deadline for investors is fast approaching.

Class Period: Jan. 25, 2019 - Nov. 15, 2019
Lead Plaintiff Deadline: Jan. 27, 2020
Sign Up Now: www.hbsslaw.com/investor-fraud/HEXO
Contact An Attorney Immediately: HEXO@hbsslaw.com
         844-916-0895

Hagens Berman’s HEXO Securities Class Action:

According to the detailed Complaint filed by Hagens Berman, Defendants misled investors throughout the Class Period by making materially false and/or misleading statements, as well as failing to disclose material adverse facts about the Company’s business, operations, and prospects.

Specifically, the Complaint alleges Defendants failed to disclose to investors that: (1) HEXO’s reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The truth emerged through a series of disclosures occurring between Oct. 4, 2019 and Nov. 15, 2019, when the Company announced it was producing cannabis in a section of its Niagara facility that was not properly licensed with Health Canada.

As a result of these disclosures, the value of HEXO stock has consistently decreased, damaging investors.

Most recently, on Jan. 2, 2020, the Company filed its restated annual financial statements for the fiscal year ended July 31, 2019 and its restated interim financial statements for the three months ended Oct. 31, 2019.  Among other things, the Company increased its impairment loss on inventory by about 14% for the fiscal year and announced material weaknesses in internal controls over financial reporting.

 “We’re focused on investors’ losses and proving Defendants knowingly provided false financial information to the market,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased HEXO common stock during the Class Period and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding HEXO should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email HEXO@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895

 

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.